results: In 16 countries where all clinics reported to the IVF register, 1115 cycles were performed per million inhabitants. For IVF, the clinical pregnancy rates per aspiration and per transfer were 26.9% and 30.3%, respectively. For ICSI, the corresponding rates were 28.5% and 30.9%. After IUI-H, the clinical pregnancy rate was 12.6% per insemination in women ,40. After IVF and ICSI, the distribution of transfer of one, two, three and four or more embryos was 20.0%, 56.1%, 21.5% and 2.3%, respectively. Huge differences exist between countries. The distribution of singleton, twin and triplet deliveries after IVF and ICSI was 78.2%, 21.0% and 0.8%, respectively. This gives a total multiple delivery rate of 21.8% compared with 22.7% in 2004 and 23.1% in 2003. In women ,40 years of age, IUI-H was associated with a twin and triplet pregnancy rate of 11.0% and 1.1%, respectively.
Introduction
This report is the ninth annual European Society of Human Reproduction and Embryology (ESHRE) publication on European data on assisted reproductive technology (ART). The eight previous reports, also published in Hum Reprod (ESHRE, 2001a (ESHRE, , b, 2002 (ESHRE, , 2005 (ESHRE, , 2006 (ESHRE, , 2007 (ESHRE, , 2008 , covered treatment cycles from 1997 to 2004 .
Data have been collected from 30 European countries on ART covering IVF, ICSI, frozen embryo replacement (FER), oocyte donation (ED), in vitro maturation (IVM) and pooled data on preimplantation genetic diagnosis (PGD) and screening (PGS) during 2005. In addition to ART treatments, data on intrauterine inseminations using husband/ partner's semen (IUI-H; 21 countries) and donor semen (IUI-D; 16 countries) were also included.
The annual meeting with the European IVF Monitoring (EIM) Consortium was held at the ESHRE meeting in Barcelona in July 2008 with representatives from the participating countries. The present and future reporting systems were discussed. Croatia and the Czech Republic were able to provide data for 2005, and the Turkish National ART Register provided data from 61 out of 93 clinics in the country.
The Consortium noted that the proportion of clinics reporting data had risen substantially in Italy and Spain, but needed to increase in Greece. In Eastern Europe, a number of countries do not yet participate in the EIM.
The reporting forms used for the 2005 data are similar to previous years, but the Consortium agreed on new forms, in order to gradually increase the quality and value of the data. One major change that will take effect from next year is stratification of results by female age.
The Consortium decided to continue to present annual reports and try to improve the quality of the reports.
Materials and Methods

Data collection
The present report summarizes data from ART treatments, including IVF, ICSI, ED, FER, PGD/PGS, IVM, IUI-H and IUI-D started between the 1 January 2005 and the 31 December 2005. Follow-up data on pregnancies and deliveries are based on those treatments carried out during the reporting period. For IUI, only pregnancies, and not deliveries, were recorded. The number of clinics reporting IUI data may differ from the number of clinics presenting data on the in vitro techniques.
The principles of reporting 2005 data are basically similar to those preceding years (ESHRE, 2001a (ESHRE, , b, 2002 (ESHRE, , 2005 (ESHRE, , 2006 (ESHRE, , 2007 (ESHRE, , 2008 .
As it is evident from the tables, registers from a number of countries have been unable to provide some of the data required. As the data presented here are incomplete and generated through different methods using partly different definitions in different countries, the data need to be interpreted with caution. Table I shows the number of all treatment cycles recorded in each country, the number of clinics in the country and the number of clinics reporting to the register. The cycles are subdivided into treatment modalities such as IVF, ICSI, FER, ED, IVM and PDG/PGS. In Belgium, Iceland, Lithuania and Portugal, the number of oocyte recoveries were used, as the number of initiated cycles was not available. In total, 923 clinics out of 1134 from 30 countries reported 418 111 cycles.
Results
Number of treatment cycles
Among the 321 403 fresh cycles, the distribution between IVF (118 074) and ICSI (203 329) was 36.7% and 63.3%, respectively. The proportion of FER cycles compared with 'fresh' cycles was 79 140/321 403 (24.6%). Table II shows data from those 16 countries where all clinics have reported to the register. The number of cycles is associated with the total population in the country as well as with the number of females of reproductive age (15 -49 years) . Additionally, the number of infants born after ART is expressed as a percentage of the total number of live born in the country. Overall, 258 516 cycles were undertaken in a population of 274.2 million, giving a mean of 1115 cycles per million. On average, four cycles were performed per 1000 women of reproductive age. The proportion of infants born after ART in the 16 countries ranged from 0.1% to 3.9% of all live born children. Table III shows the size distribution of the reporting clinics. The size of a clinic (or unit) is based on all cycles performed per year.
Size of the clinics
The distribution of clinics according to the number of cycles provided varied considerably among the countries. Among the larger countries, it could be noted that in Italy, 44% of the clinics provided fewer than 100 cycles annually, whereas in Belgium, 44% of the clinics performed .1000 cycles a year. In the Netherlands (where satellite stimulated cycles are frequent), 77% of the clinics handling the gametes performed .1000 cycles annually. Table IV shows the age distribution of those women treated with IVF or ICSI in various countries. Table V shows the number of embryos transferred after IVF and ICSI combined. The total number of single embryo transfers (SETs) was 47 348 (20.0%). Double embryo transfers (DET) numbered 132 683 (56.1%), triple embryo transfers 50 841 (21.5%) and four or more embryo transfers occurred in 5436 (2.3%) cycles. As indicated in this table, major differences were seen between countries. In 2005, several countries reported a large number of SETs. The highest levels were found in Sweden (69.4%), Finland (49.7%), Belgium (48.0%), Denmark (32.6%) and Slovenia (30.0%). The proportion of triple embryo transfers ranged from zero in Sweden to 50.4% in Italy. Transfer of four or more embryos ranged from 0% in several countries to 35.8% in Lithuania.
Age distribution
Number of embryos transferred
Pregnancies and deliveries after treatment
Tables VI -IX show the number of pregnancies and deliveries in relation to the number of initiated cycles, aspirations and transfers for IVF (Table VI), ICSI (Table VII) , FER (Table VIII) and ED (Table IX) . In Tables VI -IX , the delivery rates per embryo transfer have not been summarized due to incompleteness or absence of follow-up of pregnancies in many countries.
Singleton, twin, triplet and quadruplet deliveries Table X shows the deliveries after IVF and ICSI in relation to singleton, twin and triplet deliveries. The distribution of the deliveries was as follows: singleton 37 487 (78.2%), twin 10 067 (21.0%) and triplet 396 (0.8%). Table XI shows deliveries after FER in relation to singleton, twin and triplet deliveries. It is shown that the distribution of the deliveries was as follows: singleton 7303 (85.6%), twin 1191 (13.9%) and triplet 38 (0.4%).
Preimplantation genetic diagnosis/screening
Data on PGD/PGS activity were available from 13 countries (Table I) embryo transfers, 1388 pregnancies (32% per transfer) and 780 deliveries.
In vitro maturation
As shown in Table I , IVM was recorded in eight countries. A total of 247 aspirations were recorded, resulting in 23 pregnancies (9% per aspiration). In women at .40 years, the corresponding figures were 8295, 617 and 7.4%.
Complications and fetal reductions
Intrauterine inseminations
In women ,40, singleton, twin and triplet pregnancies accounted for 87.9%, 11.0% and 1.1% of the pregnancies, respectively, whereas in women .40, the corresponding figures were 94.4%, 4.9% and 0.7%. Table XIV gives data on IUI-D stratified by female age groups ,40 years (upper panel) and 40 years or more (lower panel). For France, no stratification for age was available, and the overall results are included in the group ,40 years of age.
In women ,40 years of age, 18 515 treatments resulted in 3498 pregnancies giving a pregnancy rate per insemination of 18.9%. In women at 40 years or above, the corresponding figures were 2053, 189 and 9.2%.
In women ,40, singleton, twin and triplet pregnancies accounted for 88.0%, 10.8% and 1.2% of the pregnancies, respectively, whereas in women .40, the corresponding figures were 93.5%, 6.5% and 0%.
Cumulative delivery and multiple delivery rates 
Comments
The present report is the ninth consecutive, annual European report on ART data. Together these reports cover treatment cycles from 1997 to 2005. It can be argued that as long as data are incomplete, generated through different methods of data collection and use partly different definitions, the results should not be summarized, as occurs in this report. Therefore, the focus should primarily be on specific country data rather than on summary data. In 2005, the number of countries reporting to ESHRE's EIM Consortium increased to 30 covering the whole of Western Europe. For 2005, Turkey contributed almost 30 000 cycles covering the majority of centres in the country. In Eastern and South Eastern Europe, no data were available from the following countries: Estonia, Latvia, Bosnia, Romania and Slovakia.
In the report from 2004, the number of cycles from Germany declined to only 57 000 cycles compared with above 102 000 cycles in 2003. The present data show that this decline, which was due to the introduction of a more restrictive re-imbursement policy, in January 2004, is still present in 2005, with the number of treatments totalling 53 000. The German example provides good evidence that a public re-imbursement policy of ART has a major impact on the number of treatments.
Overall Greece: the total number of 16 also includes centres with IUI only and IVF was performed in 15 centres. Spain: the total number of 131 also includes centres with IUI only and IVF was performed in 98 centres.
Assisted reproductive technology (ART) in Europe, 2005 National ART register in Turkey in the present report. In addition, the present report includes data from almost 150 000 IUI cycles. Within Europe, the largest number of ART cycles were reported from France (71 000), Germany (53 000), Spain (42 000) and the UK (42 000). This compares globally with 134 000 cycles from the USA (CDC, 2007) We still do not have a complete European dataset, as the present report included data from 923 of 1134 (81%) of all centres in the reporting countries. Additionally, we believe that those clinics that do not report are likely to be smaller in size than those that do report. In Greece, only 16 of 49 clinics report, but efforts are being made to establish a statutory register. As shown in Table I , the number of reporting clinics in Italy (177/194) and Spain (131/184) has increased considerably. Expansion of reporting in Italy can be explained by the fact that reporting became mandatory in 2004. It should be noted that the proportion of clinics reporting IUI may differ considerably from the number reporting on ART.
As shown in Table II , the average number of treatment cycles per million inhabitants was 1115 with a range from 46 in Albania to 2209 in Denmark. Another way to define the availability of ART is that four treatment cycles were done per 1000 women of reproductive age (15 -49 years).
The proportion of ICSI versus standard IVF procedures continued to increase (49% in 2001; 52% in 2002; 55% in 2003; 59% in 2004 and 63% in 2005 Czech Republic, the Netherlands and Turkey: no data available. For Finland, data for women aged 45 years or more are included in the age group of 40 -44 years. For France, it was estimated from the FIVNAT Register. For Poland, the age was missing in one IVF cycle. For Russia, the age was missing in four IVF, three ICSI and two ED cycles. For Sweden, the numbers refer to the number of cycles and not the number of women and will therefore not reach 100%. For the UK, data were missing in 18 IVF cycles, 15 ICSI cycles and 11 ED cycle. The age distribution of women receiving ED was known in 6331 cases (,29 years 16%, 30 -34 years 34%, 35 -39 years 30%, 40 -44 years 16% and .45 years 3%). (Jain and Gupta, 2007) . As recently reviewed, the trend towards increased use of ICSI has been observed throughout the world (Nyboe Andersen et al., 2008) . In Australia and New Zealand, 58.5% of all cycles used ICSI in 2005 and in the USA, the corresponding figure was 59.6%, so there is a very uniform development in those three regions. However, within Europe there is a marked regional variation in terms of the ratio between IVF and ICSI. As can be seen in Table I , certain countries, such as Belgium (75.0%), Germany (70.2%), Italy (72.9%), Spain (83.4%) and Turkey (97.2%), use ICSI very frequently. In the Nordic countries, the Netherlands, Russia and the UK, IVF remains the dominant technology. As recently analysed, the marked increase in the use of ICSI cannot be explained by a similar increase in male infertility but rather to a more frequent use of ICSI in cases with mixed causes of infertility, unexplained infertility and mild male factor infertility. This is however unlikely to explain the striking differences between countries, which can only be explained by professional preference (Nyboe Andersen et al., 2008) . This report also demonstrates that the number of embryos transferred in IVF and ICSI cycles differed substantially between countries, but there is a clear trend towards transfers with fewer embryos (Table V) The recording of deliveries is incomplete, see This report is unable to discriminate between the numbers of elective SET (eSET) versus SET, but the rise in the number of one embryo transfers is undoubtedly due to enhanced rate of eSET. As seen in Table V , there were six countries that reported transfer of a single embryo in .25% of all transfers: Sweden (69.4%), Finland (49.7%), Belgium (48.0%), Norway (42.8%), Denmark (32.6%) and Slovenia (30.0%). For comparison, SET was done in 48.2% of cycles in Australia and New Zealand (AIHW, 2007) .
The consistent trend towards transfer of fewer embryos is also reflected in the overall occurrence of multiple deliveries after IVF and ICSI. In 2000, the average multiple delivery rate was 26.9%, declining to 25.5% in 2001, 24.5% in 2002, 23.1% in 2003, 22.7% in 2004 and 21.8% in 2005 . During the 9 year period of EIM reporting, the most remarkable finding regarding multiple births has been the reduction in triplet deliveries from 3.6% in 1997, to 2.3% in 1998, 2.3% in 1999, 1.9% in 2000, 1.5% in 2001, 1.3% in 2002, 1.1% in 2003, 1.0% in 2004 and 0.8% in 2005. As it is evident from Table X, however, huge differences in triplet rates are still found between countries.
Fetal reductions are only done in extraordinary cases in twin gestations, but when analysing the range of triplet delivery rates in different countries, the number of fetal reductions should also be considered. A total of 436 procedures were reported, the largest numbers coming from Spain (107), the UK (99), France (62) and Greece (46). It is worth noting that although a number of countries did not report on fetal reductions, the number reported was higher than the reported number of triplet deliveries. Without fetal reductions, the proportion of triplet deliveries would indeed have been higher. Pregnancy rates for IVF, ICSI and FER were marginally increased compared with 2004. For IVF, the mean pregnancy rate per transfer was 30.3% compared with 30.1% in 2004. For ICSI, the mean pregnancy rate per transfer reached 30.9% compared with 28.9% in 2004. For FER, it was unchanged at 19.6%.
The pregnancy rates in Europe remain lower than in the USA where 42.0% of transfers from non-donor cycles resulted in a pregnancy. In thaw cycles, the live birth rate was as high as 27.3% (CDC, 2007) . However, the pregnancy rates in Europe are very similar to what is achieved in Australia and New Zealand, where the clinical pregnancy rate per transfer was 30.6% after fresh cycles and 21.5% after FER transfers in 2005 (AIHW, 2007 .
The data on pregnancy and delivery rates presented so far in the EIM reports represent overall results for women in all age groups. At the EIM Consortium meeting in Barcelona, July 2008, it was decided to collect European data in a way that would permit stratification of the pregnancy and delivery rates in relation to age groups. The recording of deliveries is incomplete. For Russia in 119 ED cycles, no further data were available.
Assisted reproductive technology (ART) in Europe, 2005 With a noticeable decline in the number of embryos transferred, the cumulative delivery rate per started cycle may be a most relevant end-point for ART. Table XV gives a calculation of cumulative delivery rates, but it should be stressed that this does not represent the true cumulative delivery rate per cycle and per couple, and only gives an estimate based on fresh and FER cycles done during the same year. In a steady state situation, this calculation will give a rather good estimate of the true cumulative delivery rate. In several countries, the addition of FER deliveries have resulted in a substantial increase in the delivery rates per cycle: Finland (21.3% to 31.6%), Sweden (24.7% to 31.5%) and Switzerland (24.7% to 32.5%).
PGD/PGS activity was recorded from 13 countries and included 5846 cycles resulting in 1388 pregnancies (32% per transfer). Detailed reporting of PGD/PGS in Europe is published separately by ESHRE's PGD Consortium. The last report deals with data from 2005 (Goossens et al., 2008) .
With respect to direct risks of ART, OHSS was recorded in 1.2% of cycles. This was similar to figures in the preceding years and seems to argue against an increased use of mild stimulation protocols in Europe.
For the fourth consecutive year, the present report includes European data on treatments with IUI-H (129 000 cycles) and IUI-D (21 000 cycles). 
